MANGALAM DRUGS & ORGANICS LTD. - 532637 - Closure of Trading Window
Closure of trading window for Designated Persons from 1st April till 48 Hours after declaration of Financial Results for the period ended March 31 202430-03-2024
30-03-2024
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Outcome for The Board At Its Meeting Held On 15.03.2024 Considered And Approved The Scheme Of Merger By Absorption.
The Board at its meeting held on 15.03.2024 Considered and approved the scheme of Merger by Absorption.16-03-2024
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Board of Directors at its meeting held on 15th March 2024 considered and approved the scheme of Merger by Absorption.16-03-2024
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Intimation for Considering And Approval Of The Scheme Of Merger
MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/03/2024 ,inter alia, to consider and approve The proposal of Scheme of Merger08-03-2024
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Intimation Of Board Meeting To Be Held On Friday 15Th March 2024
Intimation of Board meeting to be held on Friday 15th March 202408-03-2024
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 01, 2024 for Shree Kishoriju Trading and Investments Pvt Ltd02-03-2024
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of Unaudited standalone and consolidated financial results for the period ended 31st December 202314-02-2024
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results For The Period Ended 31.12.2023
Unaudited Standalone and Consolidated Financial Results for the period ended 31.12.202313-02-2024
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December 2023
Submission of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 202313-02-2024
MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 13, 2024 for Shree Kishoriju Trading and Investments Pvt Ltd13-02-2024